Marksans Pharma
MARKSANS.NS
#5474
Rank
S$1.91 B
Marketcap
S$4.22
Share price
-2.92%
Change (1 day)
47.73%
Change (1 year)

Earnings for Marksans Pharma (MARKSANS.NS)

Earnings in 2026 (TTM): S$0.10 Billion

According to Marksans Pharma 's latest financial reports the company's current earnings are S$0.36 Billion. In 2025 the company made an earning of S$73.12 Million a decrease over its 2024 earnings that were of S$76.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Marksans Pharma from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.10 B45.69%
2025 S$73.12 M-4.7%
2024 S$76.73 M13.74%
2023 S$67.47 M42.13%
2022 S$47.47 M-7.29%
2021 S$51.2 M11.05%
2020 S$46.1 M106.8%
2019 S$22.29 M37.32%
2018 S$16.23 M33.95%
2017 S$12.12 M175.6%
2016 S$4.39 M-85.02%
2015 S$29.36 M-7.36%
2014 S$31.69 M24.21%
2013 S$25.52 M